Click Therapeutics

New York, United States Founded: 2012 • Age: 14 yrs
Mobile apps for brain disorder treatments are provided.

About Click Therapeutics

Click Therapeutics is a Healthcare company based in New York (United States) founded in 2012 by Wei Kiddy Zhou and David Benshoof Klein. Mobile apps for brain disorder treatments are provided. Click Therapeutics has raised $180.32 million across 15 funding rounds from investors including SVB, Dassault Systems and HHS. Its chief executive, as recorded, is David Benshoof Klein. Its website clicktherapeutics.com draws about 12 thousand monthly visits. Click Therapeutics offers products and services including Click SE and Prescription Digital Therapeutics. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Patient Engagement. Its legal entity is Click Therapeutics, Inc. Its competitors include Mindoula, Woebot Health and Limbix; 3 of its 3 listed competitors have raised funding.

Company details

Founded in 2012 and headquartered in New York, United States, Click Therapeutics operates in the digital health sector. Mobile applications are developed to address brain disorders and neuropsychiatric conditions, including smoking cessation, Alzheimers disease, ADHD, and traumatic brain injury. Daily activities are tracked by patients through the platform, which facilitates behavior and cognitive modifications while enabling connections to care teams.

  • Headquarters New York, United States
  • Founders Wei Kiddy Zhou, David Benshoof Klein
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website clicktherapeutics.com
  • Social LinkedIn X Facebook Instagram
  • Legal Name Click Therapeutics, Inc.
Key Metrics
  • Total Equity Funding
    $180.32M (USD)

    in 15 rounds

  • Latest Funding Round
    $50M (USD), Series D

    Apr 2026

  • Investors
    SVB

    & 13 more

Products & Services of Click Therapeutics

Click Therapeutics offers a comprehensive portfolio of products and services, including Click SE and Prescription Digital Therapeutics.

Click SE
Software-Enhanced Drugs

Combines software with pharmacotherapy for improved clinical outcomes

Prescription Digital Therapeutics
Digital Treatments

Software applications for treating diseases like migraine and depression

Apps and channels of Click Therapeutics

Click Therapeutics publishes 2 mobile apps with over 5K+ downloads.

Clickotine
Google Play Health & Fitness Everyone Free
Developer: Click Therapeutics, Inc.
View on Google Play
Clickotine
App Store Health & Fitness 17+
Developer: Click Therapeutics, Inc.
View on App Store

Funding Insights of Click Therapeutics

Click Therapeutics has successfully raised a total of $180.32M across 15 strategic funding rounds. The most recent funding activity was a Series D round of $50 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $180.32M
  • Total Rounds 15
  • Last Round Series D β€” $50M
  • First Round $1.09M

    (Oct 2014)

  • Investors Count 14

Latest 10 of 15 funding rounds of Click Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2026$50MSeries D––
Mar 2025$48.58MSeries B––
Aug 2024$8.27MDebt – Conventional––
–
May 2024$3MSeries B––
–
Apr 2022$15MDebt – Venture––
Oct 2021$52.12MSeries B–HIG BioHealth Partners, Accelmed
Dec 2020$30MDebt – Conventional––
Apr 2019$224,932Grant––
Oct 2018$19MSeries A–Sanofi Ventures
Jun 2018$224,951Grant––
Valuation history

14 investors in total: 14 institutional.

Investors in Click Therapeutics

Click Therapeutics has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Dassault Systems and HHS.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
accelmed.com
Growth-stage US tech companies are funded by Health Catalyst Capital.
healthcatalystcapital.comNew York, United States
Life-Sciences focused Early stage Corporate VC Firm investing in the US
sanofiventures.comParis, France
Hikma Ventures is focused on digital health investments.
2015hikmaventures.comLondon, United Kingdom
ridgetophealth.com
Flexible, long-term financing solutions are provided to healthcare companies.
k2hv.comBoston, United States
Early-stage tech investments are made by Supernode Ventures.
2017supernode.vcNew York, United States
SaaS-driven BIM and 3D modeling solutions are offered for construction.
19813ds.comVelizy Villacoublay, France
Banking services are provided to innovative companies, investors, and individuals.
1983svb.comSanta Clara, United States
higbio.com
Premium access

Investor details for Click Therapeutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Click Therapeutics

56 people are tracked at Click Therapeutics (25 in leadership, 1 in board & advisors, 30 in team).

NameRoleGroup
Wei Kiddy Zhou
Co-FounderLeadership
David Benshoof Klein
Co-Founder & CEOLeadership
Usha Dantu
Chief People OfficerLeadership
Brian Perrella
Director, Commercial StrategyLeadership
Han Chiu
CTOLeadership
David B. Klein
CEOLeadership
Randall Stanicky
CFOLeadership
Nathan Tran
Talent Acquisition PartnerLeadership
Austin C. Speier
Chief Strategy OfficerLeadership
Avanti Goel
Director, Commercial StrategyLeadership
Daniel Busby
Vice President, Investor Relations & Strategic FinanceLeadership
Steven L.
Associate Director, StrategyLeadership
Tony McDermott
Vice President, Global Commercial StrategyLeadership
Han C.
Chief Technology OfficerLeadership
Ritesh Manchanda
VP of EngineeringLeadership
Shubhendu Chavda
Director Cloud & Services EngineeringLeadership
Leo Park
Sr. Director of Cyber SecurityLeadership
Tarique N. Collins, JD, CIPP/US, CIPM
Chief Legal OfficerLeadership
Richard Denunzio
Chief Commercial OfficerLeadership
Tarique Collins
Chief Legal OfficerLeadership

36 more people are available in the full profile.

Premium access

Complete people profiles for Click Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Click Therapeutics

3 dated milestones of Click Therapeutics across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Click Therapeutics is founded.
  2. Funding First funding round of $1.1M.
  3. Funding Latest funding round, Series D, of $50.0M.

Competitors of Click Therapeutics

Click Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Mindoula, Woebot Health and Limbix.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
mindoula.com2013Bethesda, United States$31.05M254
Virtual care management for behavioral health is provided by Mindoula.
woebothealth.com2017San Francisco, United States$99.5M
AI-powered chat-based mental wellness tools are developed.
limbix.com2016Palo Alto, United States$27M55
VR-based exposure therapy for anxiety and phobias is provided.
Premium access

Detailed competitors of Click Therapeutics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Click Therapeutics

The website of Click Therapeutics (clicktherapeutics.com) receives about 11.5K visits a month and ranks #2,470,535 among all websites worldwide, #3,389 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    11.5K

    ▲ 23.1% vs previous month

  • Unique visitors
    4.5K

    per month

  • Global rank
    #2,470,535

    among all websites

  • Category rank
    #3,389

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Click Therapeutics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
fortressbiotech.com
100%
11.6K#2,326,761View details
otsuka-us.com
84%
105.4K#434,587View details
govhealthit.com
govhealthit.com
68%
–
celmatix.com
61%
View details
bhbusiness.com
bhbusiness.com
56%
#813,202–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for Click Therapeutics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Click Therapeutics (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Click Therapeutics

Premium access

Complete news archive for Click Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Click Therapeutics

Click Therapeutics was founded in 2012 and raised its 1st funding round 2 years after it was founded.

Click Therapeutics is headquartered in New York, United States. It is registered at New York, New York, United States.

David Benshoof Klein is the CEO of Click Therapeutics, as recorded in our data. They have also founded this company.

Click Therapeutics is a funded company, having raised a total of $180.32M across 15 funding rounds to date. The company's 1st funding round was a Grant of $224.95K, raised on Oct 2014.

Founded in 2012 and headquartered in New York, United States, Click Therapeutics operates in the digital health sector. Mobile applications are developed to address brain disorders and neuropsychiatric conditions, including smoking cessation, Alzheimers disease, ADHD, and traumatic brain injury. Daily activities are tracked by patients through the platform, which facilitates behavior and cognitive modifications while enabling connections to care teams.

Click Therapeutics's top competitors include Woebot Health, Mindoula and Limbix.

Click Therapeutics offers Click SE and Prescription Digital Therapeutics.

Click Therapeutics has 14 investors. Key investors include SVB, Dassault Systems, HHS, Revelation Partners, and HIG BioHealth Partners.

Click Therapeutics operates through Click Therapeutics, Inc..

Yes. Click Therapeutics publishes Clickotine and 1 more app, with over 5,000 downloads.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available